线粒体在RNA修饰和新陈代谢重编程影响细胞死亡,瘤微环境和免疫疗法的交叉点
Jiaxun Zhang1, Haoxuan Zhang1, Leifeng Chen2,3
1Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Journal of hematology & oncology
|December 10, 2025
概括
RNA的修改显著影响线粒体功能,影响细胞死亡,新陈代谢和免疫力. 这篇评论详细介绍了RNA修饰剂和抑制剂,强调了它们在癌症和衰老等疾病中的治疗潜力.
科学领域:
- 线粒体生物学 线粒体生物学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 线粒体对于细胞能量,新陈代谢和细胞死亡至关重要.
- RNA修饰是影响细胞过程的基因表达的关键调节者.
- 功能障碍的线粒体和改变的RNA修饰与各种疾病有关.
研究的目的:
- 综合审查RNA修饰及其影响线粒体功能的修饰剂.
- 探索RNA修饰在线粒体代谢,细胞死亡 (cuproptosis) 和动态中的作用.
- 为了研究RNA修饰,线粒体和抗瘤免疫的交集,以获得治疗见解.
主要方法:
- 关于主要RNA修饰修饰剂和小分子抑制剂的文献综述.
- 对线粒体葡萄糖代谢中的RNA修饰,调节细胞死亡和动态的当前研究进行分析.
- 探索研究将RNA修饰和线粒体与抗瘤免疫联系起来.
主要成果:
- RNA的修改极大地影响了氧化酸化,cuproptosis和线粒体动态.
- 在RNA修饰和线粒体功能之间存在一个复杂的调节网络.
- RNA修改为增强癌症免疫疗法的潜在治疗标.
结论:
- RNA修饰是线粒体功能的重要调节者,对健康和疾病有重大影响.
- 准RNA修饰途径为线粒体功能障碍,癌症和与衰老相关的疾病提供了新的治疗策略.
- 对RNA修饰-线粒体相互作用的进一步研究可以为疾病治疗和免疫疗法增强开辟新的途径.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Mitochondria
19.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.5K
Mitochondrial Membranes
16.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


